Crossmark

Policosanol Pretreatment Protects against Acute Liver Injury through Targeting MAPK, SIRT1, PPAR-γ and NF-κB in Rats

Published Online: 2026-04-17

Published Print: 2026-08

Authors

Hamouda, Samar O.

Zaghloul, Marwa S. https://orcid.org/0000-0002-7082-481X
Sharawy, Maha H.
Funding

Funding for this research was provided by:

Mansoura University
License Information

Text and Data Mining valid from 2026-04-17

Version of Record valid from 2026-04-17
More Information

Article History

Received: 3 December 2025

Accepted: 10 March 2026

First Online: 17 April 2026

Declarations

:

: All animal experiments have been performed in accordance with the Basic & Clinical Pharmacology & Toxicology (BCPT) policy for experimental and clinical studies (Tveden-Nyborg et al., 2023) and was accepted by the Faculty of Pharmacy’s Institutional Animal Care and Use Committee (ACUC) at Mansoura University in Egypt (Approval no: MU-ACUC (PHARM.MS.23.07.18).

: All authors confirm that this manuscript has not been published elsewhere and is not under consideration by another journal. All authors have approved the manuscript and authorship order and agree with submission to BMC Pharmacology and Toxicology.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current